Stanley Druckenmiller Incyte Corp Transaction History

Duquesne Family Office LLC

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$72.82 - $86.52 $14.7 Million - $17.5 Million
-202,400 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$63.56 - $88.17 $12.9 Million - $17.8 Million
202,400 New
202,400 $17.4 Million
Q4 2017

Feb 14, 2018
SELL
$93.56 - $116.6 $7.05 Million - $8.79 Million
-75,400 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$109.15 - $138.27 $8.23 Million - $10.4 Million
75,400
75,400 $8.8 Million

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track Stanley Druckenmiller's Portfolio

Track Stanley Druckenmiller Portfolio

Follow Stanley Druckenmiller (Duquesne Family Office LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email